Ra Medical Systems
| General Information | |
| Business: |
We are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. In June 2018, we completed our 12 month commercial launch period, which included training, production, and staffing for the marketing of the DABRA laser system and disposable catheter, together referred to as DABRA, in the United States. |
| Industry: | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees: | 75 |
| Founded: | 2002 |
| Contact Information | |
| Address | 2070 Las Palmas Drive, Carlsbad, CA 92011, US |
| Phone Number | (760) 804-1648 |
| Web Address | http://www.ramed.com |
| View Prospectus: | Ra Medical Systems |
| Financial Information | |
| Market Cap | $205.8mil |
| Revenues | $5.4 mil (last 12 months) |
| Net Income | $-15.9 mil (last 12 months) |
| IPO Profile | |
| Symbol | RMED |
| Exchange | NYSE |
| Shares (millions): | 3.9 |
| Price range | $17.00 - $17.00 |
| Est. $ Volume | $66.3 mil |
| Manager / Joint Managers | Piper Jaffray/ Cantor |
| CO-Managers | SunTrust Robinson Humphrey/ Nomura/ Maxim Group |
| Expected To Trade: | 9/27/2018 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |